ENE.WAR Centrum Medyczne ENEL-MED SA
- Market cap
- PLN 571M
- P/E
- 33.7x
- P/B
- 2.96x
- ROE
- 7.7%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is ENE.WAR undervalued?
Graham numberENE.WAR trades 110.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Centrum Medyczne ENEL-MED SA fundamental analysis
5 of 22 checks passedROE 0/2
Low return on equity (7.7%), below 10%.
ROA 0/1
Return on assets (2.3%) is below the industry median (2.7%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-11.8%) is below the industry median (1.4%).
Revenue Growth 2/2
Revenue grew 20.0% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (187.8%), above 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
EBIT is 1.8x against interest expense, below 5x.
PE vs Market 0/1
PE (33.7x) is above the market median (11.6x).
PE vs Industry 0/1
PE (33.7x) is above the industry median (22.9x).
PBV 0/1
Price to book (3.0x) is above the industry median (1.4x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 99.5, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Centrum Medyczne ENEL-MED SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Centrum Medyczne ENEL-MED SA
Centrum Medyczne ENEL-MED S.A., together with its subsidiaries, operates hospitals in Poland, Austria, France, the United Kingdom, and internationally. It offers various medical services comprising pediatric specialist consultations, dentistry, orthopedic, rehabilitation, psychological, imaging and diagnostics, laboratory diagnostics, and emergency care services. The company also provides vaccination services for adult and children. Centrum Medyczne ENEL-MED S.A. was founded…
Full company profileCentrum Medyczne ENEL-MED SA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Centrum Medyczne ENEL-MED SA annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 274M | 324M | 372M | 418M | 400M | 441M | 495M | 619M | 736M | 854M | 958M |
| Gross Profit | 21.7M | 18.1M | 23.5M | 23.6M | 30.3M | 22.2M | 10.9M | 26.0M | 58.5M | 79.6M | 94.3M |
| Operating Income | 4.36M | -1.90M | 1.59M | 6.69M | 15.9M | 4.68M | -20.8M | 2.99M | 27.9M | 20.4M | 35.4M |
| EBITDA | 20.9M | 17.8M | 23.4M | 63.1M | 70.3M | 63.3M | 40.0M | 91.1M | 105M | 102M | 122M |
| Net Income | 1.83M | -3.31M | -735K | -2.47M | -3.40M | -1.41M | -23.6M | 8.23M | 14.6M | 12.9M | 14.9M |
| EPS | 0.08 | -0.14 | -0.03 | -0.10 | -0.14 | -0.06 | -0.83 | 0.29 | 0.52 | 0.46 | 0.53 |
| Balance Sheet | |||||||||||
| Total Assets | 196M | 208M | 217M | 414M | 393M | 442M | 432M | 476M | 537M | 642M | 659M |
| Total Liabilities | 87.5M | 102M | 113M | 312M | 294M | 265M | 280M | 316M | 364M | 456M | 466M |
| Shareholders' Equity | 109M | 106M | 105M | 102M | 98.9M | 177M | 152M | 160M | 173M | 186M | 193M |
| Cash & Short-term Investments | 13.6M | 13.3M | 8.17M | 9.51M | 19.1M | 76.2M | 24.9M | 26.1M | 38.8M | 35.3M | 35.5M |
| Total Debt | 43.6M | 53.5M | 54.7M | 259M | 245M | 199M | 218M | 236M | 275M | 342M | 363M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 17.2M | 24.0M | 14.9M | 74.8M | 74.4M | 67.2M | 40.0M | 81.0M | 103M | 99.4M | 115M |
| Capital Expenditure | 25.9M | 28.7M | 20.0M | 29.4M | 10.9M | 38.6M | 45.9M | 32.8M | 44.9M | 77.6M | 102M |
| Free Cash Flow | -8.64M | -4.75M | -5.02M | 45.4M | 63.4M | 28.5M | -5.90M | 48.3M | 58.3M | 21.8M | 13.2M |
| Ratios | |||||||||||
| ROE | 1.7% | -3.1% | -0.7% | -2.4% | -3.4% | -0.8% | -15.5% | 5.1% | 8.5% | 6.9% | 7.7% |
| ROA | 0.9% | -1.6% | -0.3% | -0.6% | -0.9% | -0.3% | -5.5% | 1.7% | 2.7% | 2.0% | 2.3% |
| Net Profit Margin | 0.7% | -1.0% | -0.2% | -0.6% | -0.8% | -0.3% | -4.8% | 1.3% | 2.0% | 1.5% | 1.6% |
| Debt to Equity | 0.40x | 0.50x | 0.52x | 2.53x | 2.47x | 1.13x | 1.43x | 1.47x | 1.59x | 1.84x | 1.88x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Centrum Medyczne ENEL-MED SA dividends
Centrum Medyczne ENEL-MED SA has not paid dividends in the last 9 fiscal years.
Who owns Centrum Medyczne ENEL-MED SA
- Insiders 51.65%
- Institutions 41.95%
- Public & others 6.39%
- Shares outstanding 28.3M
- Free float 13.7M
Centrum Medyczne ENEL-MED SA company profile
- Company name
- Centrum Medyczne ENEL-MED SA
- Ticker
- ENE.WAR
- ISIN
- PLENLMD00017
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,103
- Fiscal year end
- December
- Address
- ul. Slominskiego 19 lok. 524, Warsaw, Poland, 00-195
- Phone
- 48 22 431 7701
- Website
- enel.pl
About Centrum Medyczne ENEL-MED SA
Centrum Medyczne ENEL-MED S.A., together with its subsidiaries, operates hospitals in Poland, Austria, France, the United Kingdom, and internationally. It offers various medical services comprising pediatric specialist consultations, dentistry, orthopedic, rehabilitation, psychological, imaging and diagnostics, laboratory diagnostics, and emergency care services. The company also provides vaccination services for adult and children. Centrum Medyczne ENEL-MED S.A. was founded in 1993 and is headquartered in Warsaw, Poland.
Centrum Medyczne ENEL-MED SA management
3- Mr. Jacek Jakub RozwadowskiPresident of Management Board, MD & CEO
- Mr. Bartosz Adam RozwadowskiDirector of Investment & Purchasing and Member of the Management Board
- Ms. Zaneta BujalskaChief Accountant